Reliable Data You Can Trust
Reliable Data You Can Trust
A recent report published by
Infinium Global Research on the in-vitro transcription templates market provides an in-depth analysis of segments and sub-segments in the global as well as
regional in-vitro transcription templates market. The study also highlights the
impact of drivers, restraints, and macro indicators on the global and regional
in-vitro transcription templates market over the short term as well as long
term. The report is a comprehensive presentation of trends, forecast, and dollar
values of the global in-vitro transcription templates market. According to the
report, the global in-vitro transcription templates market is projected to grow
at a CAGR of approximately 20% over the forecast period of 2021-2027.
The revenue generated by the
market was approximately USD 218.4 billion in 2021 and is expected to reach
approximately USD 654.3 billion in 2027. A pure linear DNA template with a
promoter, ribonucleotide triphosphates, a buffer solution comprising DTT and
magnesium ions, and a suitable phage RNA polymerase are all required for in
vitro transcription. The transcription reaction's exact settings are determined
by the amount of RNA required for a specific application. Thus, synthesised RNA
transcripts are obtained from in-vitro transcription. Synthesized RNA
transcripts are further used for analysing cellular RNA functionality in
methods such as splicing, RNA processing, intracellular transport, viral
infectivity, and translation. In-vitro transcription templates are used in a
variety of applications such as drug discovery, diagnosis, and treatment of
various diseases such as chronic and genetic diseases
The prevalence of chronic diseases
such as cancer and genetic disorders and diseases is propelling the growth of
the market. The demand for early diagnosis of these diseases and effective
medical treatments and therapeutics for the same is growing rapidly.
Pharmaceutical companies are focusing on developing RNA-based diagnostics for
cancer and genetic disorders. Also, the application of in-vitro transcription
templates in targeted drug delivery and drug discovery is growing. The level of
biotechnology and further growing investments in it are also propelling the
growth of the market. Private and public funding for the development of
biotechnology is also growing, which will be beneficial for the market. The
market's growth may be stifled due to the high cost and expertise required for
the in-vitro transcription templates procedure. The growing investment in the R
& D of in-vitro transcription templates is expected to provide new growth
opportunities.
Chronic diseases such as cancer
and other genetic disorders have been prevalent in North America. The existing
diagnostics and treatments for these diseases are falling short of tackling
these diseases. Therefore, the demand for more efficient early diagnostics and
therapeutics for chronic diseases and genetic disorders is growing over time.
Thus, it has paved the way for the applications of in-vitro transcription
templates in drug discovery, precision medicine, and diagnosis methods. North
America has an advanced medical technology base with researchers having years
of experience, which has in turn greatly leveraged the R&D of in-vitro
transcription templates in North America. Additionally, huge investments from
governments and private players in the development of in-vitro transcription
templates have catapulted the market. Also, North America is a domestic market
for market players such as Thermo Fisher Scientific, Inc., Agilent
Technologies, Inc., Synbio Technologies, and Promega Corporation. With such a
high concentration of companies, the growth of the market in North America has
been exponential.
The report on global in-vitro
transcription templates market covers segments such as disease, treatment type,
and end users. On the basis of disease, the sub-markets include lifestyle
diseases, cancer, genetic disease, and others. On the basis of treatment type,
the sub-markets include vaccine, and therapeutic. On the basis of end users,
the sub-markets include biotechnology companies, research and academic
institutions, pharmaceutical companies, and others.
The report provides profiles of
the companies in the market such as Agilent Technologies, Inc., Thermo Fisher
Scientific, Inc., Enzynomics co Ltd., Promega Corporation, Enzo Life Sciences,
Inc., Takara Bio Company, Qiagen NV, Danaher Corporation, Lucigen Corporation,
and Synbio Technologies.
The report provides deep insights
into the demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings an insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of in-vitro transcription templates market. Moreover, the study
highlights current market trends and provides forecast from 2021-2027. We also
have highlighted future trends in the market that will affect the demand during
the forecast period. Moreover, the competitive analysis given in each regional
market brings an insight into the market share of the leading players.
Please Choose One of them.